Selank and Semax are often mentioned in the same breath, and for understandable reasons. Both are short synthetic peptides, both carry the same three-amino-acid extension, and both have been studied largely by the same national research community.
They are not variations of one compound, though. Each is built on a different parent molecule, and the published literature has studied them in different experimental settings. This guide compares them as research subjects. A&A Wellness supplies both strictly for research use; they are not for human or veterinary use.
The Shared Design: A Pro-Gly-Pro Extension
Both peptides are constructed the same way: a short fragment of a naturally occurring peptide, extended at the C-terminus with Pro-Gly-Pro (PGP).
Why PGP? Short native peptides are typically broken down quickly by peptidases. The PGP extension is described in the literature as a way to increase stability against that degradation. It is the common structural thread between the two molecules and the main reason they are discussed together.
Side-by-Side Comparison
| Selank | Semax | |
|---|---|---|
| Classification | Synthetic heptapeptide | Synthetic heptapeptide |
| Parent molecule | Tuftsin (described as a “peptide analog of tuftsin”) | ACTH fragment (described as “ACTH(4-7)PGP” and as an “ACTH(4-10) analog”) |
| Mechanism as described in literature | Studied in relation to GABAergic signaling and neurotrophin (BDNF) content in rodent models | Studied in relation to gene and protein expression in ischemia models and in neuroimaging of healthy volunteers |
| Typical experimental models | Rodent stress, anxiety-behavior, and ethanol models | Rodent cerebral ischemia models; resting-state fMRI in healthy volunteers |
| Research stage | Mostly preclinical; limited human neuroimaging | Preclinical plus limited human neuroimaging |
| US regulatory status | Not FDA-approved | Not FDA-approved; reviewed by FDA’s Pharmacy Compounding Advisory Committee in July 2026 |
Selank
What It Is
Selank is a synthetic heptapeptide that published studies describe as “a peptide analog of tuftsin.” Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg); Selank extends it with the PGP sequence.
How It Has Been Studied
Most indexed Selank research uses rodent models. Examples include:
- Stress and anxiety-behavior models. In a 2017 rat study in Behavioural Neurology, Kasian and colleagues used the elevated plus maze under unpredictable chronic mild stress. They reported that Selank combined with diazepam produced the largest reduction in anxiety-related behavior in that model (Kasian et al., 2017).
- Ethanol models. Kolik and colleagues reported that, in rats given ethanol chronically, Selank was associated with preserved performance on object-recognition tasks and changes in BDNF content in the hippocampus and prefrontal cortex (Kolik et al., 2019).
A 2021 review in the Journal of Clinical Pharmacology grouped Selank with other agents that impact GABA receptors. The authors described it as poorly studied and noted that it was being sold to US consumers as a dietary supplement, which they flagged as a concern (Doyno et al., 2021).
Read the full profile: Selank. View the research material: Selank.
Semax
What It Is
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH). Published work describes it as “ACTH(4-7)PGP”: the ACTH fragment Met-Glu-His-Phe extended with PGP. It is also commonly referred to as an ACTH(4-10) analog.
How It Has Been Studied
- Cerebral ischemia models. In a 2021 study in the International Journal of Molecular Sciences, Sudarkina and colleagues profiled brain protein expression in a rat model of transient middle cerebral artery occlusion. They reported that Semax was associated with downregulation of MMP-9, c-Fos, and active JNK in cortex adjacent to the lesion (Sudarkina et al., 2021).
- Human neuroimaging. Lebedeva and colleagues used resting-state fMRI in 24 healthy volunteers and reported differences in a subcomponent of the brain’s default mode network after intranasal Semax compared with placebo (Lebedeva et al., 2018).
Read the full profile: Semax. View the research material: Semax.
Where the Two Meet in the Literature
At least one study examined both peptides directly. Panikratova and colleagues performed resting-state fMRI in 52 healthy volunteers before and after administration of Selank, Semax, or placebo. They reported both general and compound-specific effects on functional connectivity between the right amygdala and the right temporal cortex (Panikratova et al., 2020).
What this does and does not show. A small, short-duration imaging study can show that two compounds produce measurably different signals. It cannot establish clinical effects. For researchers, its value is methodological: it shows the two peptides being treated as distinct experimental variables within one protocol.
Reading This Literature Critically
Geographic concentration. Most indexed research on both peptides comes from Russian groups and is published in a limited set of journals. That does not invalidate it, but independent replication is limited.
Model dependence. Rodent behavior models, such as the elevated plus maze, are standard tools, but findings in them do not translate directly to other species.
Small human samples. The human studies cited here are neuroimaging studies in healthy volunteers with small samples, not controlled clinical trials of any outcome.
Regulatory Status
- FDA approval. Neither Selank nor Semax is an FDA-approved drug.
- Compounding review. FDA’s page on bulk drug substances that may present significant safety risks lists both “Selank acetate” and “Semax (heptapeptide)” among nominations that were previously in category 2 and were later withdrawn by the nominators (FDA). Semax was among seven peptides reviewed at FDA’s Pharmacy Compounding Advisory Committee meeting on July 24, 2026, in connection with possible inclusion on the section 503A bulks list (FDA). Advisory committee recommendations are not binding, and compounding rules apply to pharmacies, not to research-reagent suppliers.
Our US regulatory overview explains these categories in more detail.
Handling and Documentation
Both peptides are commonly supplied lyophilized. See lyophilized peptides explained and the peptide storage guide for general conventions. Confirm identity against the batch documentation using our guide to reading a COA. Read more about our standards on the Quality page.
Browse Selank, Semax, or the full research peptides category.
Sources
- Kasian A, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017
- Kolik LG, et al. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating BDNF Content in Rats. Bull Exp Biol Med. 2019
- Sudarkina OY, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. Int J Mol Sci. 2021
- Lebedeva IS, et al. Effects of Semax on the Default Mode Network of the Brain. Bull Exp Biol Med. 2018
- Panikratova YR, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020
- Doyno CR, et al. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. J Clin Pharmacol. 2021
- FDA. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee
- FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks








